✓ Medically Reviewed Monograph

Enalapril Maleate

Also known as / Synonyms: Enalapril, Enalaprilat precursor

ACE inhibitor lowering elevated blood pressure and improving survival in heart failure and LV dysfunction.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Enalapril Maleate
Active Ingredient: Enalapril Maleate
Dosage Form: Tablet
Available Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral
Popular Verified Brands:
Envas Vasotec Nuril Enam Dilvas (India)
Regulatory Standards: CDSCO approved; Schedule H prescription drug. Essential cardiovascular medicine.
🎯

Approved Indications & Medical Uses

  • Treatment of essential and renovascular hypertension.
  • Symptomatic heart failure as guideline-directed therapy (with diuretics and digitalis).
  • Asymptomatic left ventricular dysfunction (LVEF <= 35%) to reduce hospitalization and mortality.
🚫

Contraindications (Do Not Use If…)

  • History of angioedema related to previous ACE inhibitor therapy or hereditary/idiopathic angioedema.
  • Concomitant use with aliskiren in patients with diabetes or renal impairment.
  • Concomitant use with neprilysin inhibitors (sacubitril/valsartan) within 36 hours (angioedema risk).
  • Second and third trimesters of pregnancy (fetal toxicity/death).
  • Bilateral renal artery stenosis.
🛡️

Important Clinical Precautions & Warnings

  • Fetal toxicity: Discontinue immediately when pregnancy is detected; causes oligohydramnios, skull hypoplasia, and fetal death.
  • Angioedema: Can affect face, lips, tongue, glottis, and bowel; airway compromise requires emergency epinephrine.
  • Hypotension: First-dose hypotension can occur in volume- or salt-depleted patients.
  • Hyperkalemia: Monitor serum potassium, especially with potassium supplements or renal impairment.
  • Renal function deterioration: Monitor serum creatinine during initiation.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Approved for hypertension in children >= 1 month; not recommended in GFR < 30 mL/min. Elderly: Start at lower dose (2.5 mg) due to decreased renal clearance.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Persistent dry hacking cough, dizziness, headache, fatigue, hypotension, diarrhea, and nausea.

🚨 Serious Side Effects — Seek Urgent Medical Care

Laryngeal angioedema, acute renal failure, life-threatening hyperkalemia, neutropenia/agranulocytosis, and hepatic failure/cholestatic jaundice.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Potassium-sparing diuretics (spironolactone, eplerenone) and potassium supplements: high risk of severe hyperkalemia.
  • NSAIDs (ibuprofen, naproxen): attenuate antihypertensive effect and worsen acute kidney injury.
  • Lithium: decreased renal clearance of lithium leading to lithium toxicity.
  • Sacubitril/valsartan: strictly contraindicated within 36 hours due to angioedema risk.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Contraindicated

Contraindicated in pregnancy (especially 2nd and 3rd trimesters). Can cause fetal renal failure, oligohydramnios, skeletal deformities, and neonatal death.

Lactation & Breastfeeding:

Use with caution — see notes

Enalapril and enalaprilat are excreted in breast milk in small amounts; use with caution in full-term infants, avoid in preterm infants.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store below 30°C in a dry place. Protect from moisture and excessive heat.

⏱️ Missed Dose Protocol:

Take once or twice daily with or without food. If missed, take upon remembering unless close to next scheduled dose.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Enalapril Maleate →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Enalapril Maleate Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/enalapril/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.